Fundz

Lumanity Acquires Innovative Edge

PRIVATEMar 30, 2022

Acquiring Company

Lumanity

Acquired Company

Innovative Edge

Data And AnalyticsHealth CareScience And EngineeringOtherFinancial ServicesCommerce And ShoppingHealth Care

Description

Lumanity today announced the acquisition of Innovative Edge ("IE"), a leading provider of pharmaceutical product launch services. The terms of the transaction were not disclosed.

Other recent acquisitions in Data And Analytics and Science And Engineering

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Lumanity, and when

When Lumanity changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Lumanity raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Lumanity, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Lumanity. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Lumanity

About

Lumanity applies incisive thinking and decisive action to cut through complex situations and deliver transformative outcomes to accelerate and optimize access to medical advances. With deep experience in medical, commercial, and regulatory affairs, Lumanity transforms data and information into real-world insights and evidence that power successful commercialization and empower patients, providers, payers, and regulators to take timely and decisive action. With offices in North America, the United Kingdom, Europe, and Asia, and work conducted in over 50 countries, Lumanity has 1,200+ experts working with top pharmaceutical and biotech companies to: identify and generate the evidence needed to demonstrate the value of their products and bring them to patients at a price reflective of that value; translate science and data into compelling product narratives that are relevant to stakeholders around the world; and, enable commercial decisions that position these products for sustainable success in the market. Turning aspiration into reality, Lumanity helps to deliver successful development strategies, payer submissions, commercial brand launches, and product campaigns. For more information, please visit lumanity.com and connect with Lumanity on Twitter and LinkedIn

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Lumanity makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Lumanity's next move

Learn about Strategic plan

Frequently asked

Who acquired Innovative Edge?

Innovative Edge was acquired by Lumanity. The deal was reported on March 30, 2022. Lumanity applies incisive thinking and decisive action to cut through complex situations and deliver transformative outcomes to accelerate and optimize access to medical advances. Lumanity is privately held and operates in Data And Analytics.

When did Lumanity acquire Innovative Edge?

Lumanity's acquisition of Innovative Edge was reported on March 30, 2022. Lumanity today announced the acquisition of Innovative Edge ("IE"), a leading provider of pharmaceutical product launch services. The terms of the transaction were not disclosed. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Innovative Edge do?

Innovative Edge (IE) is the Launch Excellence Partner of choice for world-leading pharmaceutical companies – from Top 20 pharma to fast-growing biotechs. It is privately held, operating in Other.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.